gestational diabetes mellitus

Pick Up and Oocyte Management

Pregnancy-related cardiovascular complications are rare clinical conditions that can lead to significant maternal morbidity and mortality. With the implementation of infertility treatment, a new selected population of woman can experience pregnancy. Women with multiple medical problems and women near or beyond menopause are now able to conceive. Despite many unanswered questions, clinicians should be prepared for the challenges and potential cardiovascular complications related to patients who are epidemiologically different than those seen in the past.

Cervicovaginal bacteria and fungi in pregnant diabetic and non-diabetic women. a multicenter observational cohort study

Abstract. – OBJECTIVE: We evaluated the prevalence
of cervicovaginal Bacteria, group B Streptococcus
(GBS), Gardnerella vaginalis (GV), Candida
spp., Chlamydia trachomatis (CT), Mycoplasma
hominis (MH) and Ureaplasma urealyticum
(UU) in pregnant women with and without diabetes
mellitus (DM).
PATIENTS AND METHODS: Cervicovaginal
swabs were gathered from 473 pregnant patients
divided into 127 diabetic and 346 non-diabetic. The
results were correlated to gestational age, parity
and glycemic control.

Cross-talk between fetal membranes and visceral adipose tissue involves HMGB1–RAGE and VIP–VPAC2 pathways in human gestational diabetes mellitus

Aims: Gestational diabetes mellitus (GDM) is defined as glucose intolerance that is first diagnosed during pregnancy. Maternal adipose tissue and fetal membranes secrete various molecules that are relevant players in the pathogenesis of GDM. This pilot study aimed to examine whether the expression of the high mobility group box 1 protein (HMGB1) and its receptor for advanced glycation end products (RAGE), and the vasoactive intestinal peptide (VIP) and its receptors (VPAC-1,-2) were modified in pregnant women with GDM.

Gestational diabetes mellitus: the impact of carbohydrate quality in diet

Gestational diabetes mellitus (GDM) is defined as "glucose intolerance that is first diagnosed during pregnancy". Mothers with GDM and their infants may experience both short and long term complications. Dietary intervention is the first therapeutic strategy. If good glycaemic control is not achieved, insulin therapy is recommended. There is no consensus on which nutritional approach should be used in GDM. In the last few years, there has been growing evidence of the benefits of a low glycaemic index (LGI) diet on diabetes and cardiovascular disease.

Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications

Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance that develops in the second or third trimester of pregnancy. GDM can lead to short-term and long-term complications both in the mother and in the offspring. Diagnosing and treating this condition is therefore of great importance to avoid poor pregnancy outcomes. There is increasing interest in finding new markers with potential diagnostic, prognostic and therapeutic utility in GDM.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma